House Republicans use FDA appropriations bill to override REMS changes on abortion pill

The Re­pub­li­can-led House Ap­pro­pri­a­tions Com­mit­tee on Wednes­day ad­vanced the 2024 FDA spend­ing bill by a 34-27 vote af­ter De­moc­rats failed to re­move lan­guage in the bill that would nul­li­fy changes the FDA made to the risk eval­u­a­tion and mit­i­ga­tion strat­e­gy (REMS) for the abor­tion pill mifepri­s­tone in Jan­u­ary.

Those FDA changes had eased ac­cess to mifepri­s­tone by al­low­ing cer­tain phar­ma­cies to dis­pense the pill, which is used in com­bi­na­tion with an­oth­er med­i­cine to end ear­ly preg­nan­cies.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN